Please use this identifier to cite or link to this item: https://dspace.ncfu.ru/handle/20.500.12258/19029
Title: Effect of coronavirus disease (Covid-19) on hemostasis system in patients with acute cerebrovascular accidents
Authors: Anfinogenova, O. I.
Анфиногенова, О. И.
Melchenko, E. A.
Мельченко, Е. А.
Muratova, A. Y.
Муратова, А. Ю.
Domenyuk, S.
Доменюк, С.
Vlasov, A. A.
Власов, А. А.
Elkanova, A. B.
Эльканова, А. Б.
Keywords: Coronavirus;Cardiovascular diseases;Coronavirus infection 2019;SARS-CoV-2;COVID-19;Hemostasis;Acute cerebrovascular accident
Issue Date: 2021
Publisher: EUROPAISCHE WISSENSCHAFTLICHE GESELLSCHAFT EV
Citation: Anfinogenova, O., Melchenko, E., Muratova, A., Kochkonyan, T., Domenyuk, S., Vlasov, A., Elkanova, A., Domenyuk, D. Effect of coronavirus disease (Covid-19) on hemostasis system in patients with acute cerebrovascular accidents // ARCHIV EUROMEDICA. - 2021. - Volume 11. - Issue 6. - Page 55-61. - DOI10.35630/2199-885X/2021/11/6.14
Series/Report no.: ARCHIV EUROMEDICA
Abstract: Acute viral respiratory infections add to the progression risk of the already existing pathologies, including those of cardiovascular origin. Life-threatening complications emerging against SARS-CoV-2 (severe acute respiratory syndrome), which causes COVID-19 (Coronavirus disease 2019), explain the need to study the cardiovascular effects of COVID-19 in order to offer rational medical care to patients belonging to various age categories. This article presents a comprehensive assessment of changes affecting the main hemostasis parameters in patients with acute cerebral circulatory disorders against the SARS-CoV-2 virus infection. There is special attention paid to the pathophysiological features occurring against the infectious process involving the hemostasis system. Our data shows that the differences in the main hemostatic parameters in patients with acute cerebral circulatory disorders occurring against the SARS-CoV-2 virus infection are due to the degree of the body responsiveness and the severity of the comorbid pathology. Reducing the risk of adverse conditions developing in this category of patients is possible in case of responsible monitoring focusing on the main indicators of the cardiovascular system status, as well as provided there are advanced approaches introduced in order to prevent and treat thrombotic/thromboembolic complications.
URI: http://hdl.handle.net/20.500.12258/19029
Appears in Collections:Статьи, проиндексированные в SCOPUS, WOS

Files in This Item:
File SizeFormat 
WoS 1364 .pdf
  Restricted Access
794.49 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.